ÂÜÀòÂÒÂ×

Gil Kerbs serves as the Head of Dealflow and New Investments at Teuza, where responsibilities include overseeing investment strategies and serving on the investment committee. Gil is also an active investor and board member at GyneCheck and EndoCure Ltd., and holds a board member position at PV Nano Cell Ltd. Previous ventures include founding Newt, a company focused on developing AI for personalized nutrition, and leading a substantial team at Medtronic as Business Director for the China Value Segment. Gil’s educational background includes an MBA from The Wharton School and a Master's in International Relations from the University of Pennsylvania, complemented by a BSc in Electrical Engineering from the Technion.